Comex Reports Bermuda 30 - pharmaceutical products 3002 - human or animal blood

Deploy a report





Chart - Bermuda - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - Bermuda - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - Bermuda - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Export Countries
 2020 2021 2022 2023 2024
United States 1.070.278 3.090.068 571.988 63.625 78.184
Ireland 1.413.892
France 154.200 135.413 101.335 76.093 70.081
Germany 104.935 149.708 118.289 3.731 3.227
China 32.300 304.125 3.434
Belgium 64.331 25.931 53.508 87.315 18.522
South Korea 31.000 2.000 47.000 42.000 50.000
United Kingdom 53.938
Italy 16.297 7.684 12.471 14.148
Netherlands 284 10.361 4.385 18.564
Others 335 922 2.080 1.805 1.152
Total 1,527,899 3,715,852 917,032 1,706,993 243,165

Chart - Bermuda - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - Bermuda - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - Bermuda - Imports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Export Countries
 07 - 2024 08 - 2024 09 - 2024 10 - 2024 12 - 2024
France 6.093 53.146 1.432
United States 6.986 5.635 20.016 8.844 5.449
South Korea 1.000 20.000 7.000
Netherlands 6.412
Bulgaria 1.152
Germany 1.043
Total 15,231 25,635 86,574 11,319 5,449

Chart - Bermuda - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - Bermuda - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - Bermuda - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Import Countries
 2021 2022 2023 2024
Uruguay 1.950.298 18.603.283
South Korea 15.000
France 224 420
Ireland 51
Denmark 28
Total 224 80 1,950,298 18,618,703

Chart - Bermuda - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - Bermuda - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - Bermuda - Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Import Countries
 07 - 2024 08 - 2024 09 - 2024 10 - 2024 11 - 2024 12 - 2024
Uruguay 66.870 780.345 185.827 1.243.574 1.304.345 1.158.495
Total 66,870 780,345 185,827 1,243,574 1,304,345 1,158,495

Chart - Bermuda - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Chart - Bermuda - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Table - Bermuda - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Annual FOB USD

Date
Export Countries
 2020 2021 2022 2023 2024
Importaciones
United States 1.070.278 3.090.068 571.988 63.625 78.184
Ireland 1.413.892
France 154.200 135.413 101.335 76.093 70.081
Germany 104.935 149.708 118.289 3.731 3.227
China 32.300 304.125 3.434
Belgium 64.331 25.931 53.508 87.315 18.522
South Korea 31.000 2.000 47.000 42.000 50.000
United Kingdom 53.938
Italy 16.297 7.684 12.471 14.148
Netherlands 284 10.361 4.385 18.564
Others 335 922 2.080 1.805 1.152
Total 1,527,899 3,715,852 917,032 1,706,993 243,165

Date
Import Countries
 2021 2022 2023 2024
Exportaciones
Uruguay 1.950.298 18.603.283
South Korea 15.000
France 224 420
Ireland 51
Denmark 28
Total 224 80 1,950,298 18,618,703

Chart - Bermuda - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Chart - Bermuda - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Table - Bermuda - Imports - Evolution / Exports - Evolution - NCE: human or animal blood - human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes; vaccines, toxins, cultures of microorganisms (excluding yeasts) and similar products: - Monthly FOB USD

Date
Export Countries
 07 - 2024 08 - 2024 09 - 2024 10 - 2024 12 - 2024
Importaciones
France 6.093 53.146 1.432
United States 6.986 5.635 20.016 8.844 5.449
South Korea 1.000 20.000 7.000
Netherlands 6.412
Bulgaria 1.152
Germany 1.043
Total 15,231 25,635 86,574 11,319 5,449

Date
Import Countries
 07 - 2024 08 - 2024 09 - 2024 10 - 2024 11 - 2024 12 - 2024
Exportaciones
Uruguay 66.870 780.345 185.827 1.243.574 1.304.345 1.158.495
Total 66,870 780,345 185,827 1,243,574 1,304,345 1,158,495